Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Datametrex AI Ltd V.DM

Alternate Symbol(s):  DTMXF

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.


TSXV:DM - Post by User

Post by jsim082on Jan 04, 2023 12:55pm
330 Views
Post# 35203007

Lucira looks promising

Lucira looks promising

This new partnership with Lucira looks like a very nice piece of work by DM.


Per Lucira's earnings call transcript for Q1 2022 they were receiving orders from Health Canada for the purpose of "providing value to remote and hard to reach communities". This sounds like a goal DM has also expressed.
(Source:
https://www.fool.com/earnings/call-transcripts/2022/05/13/lucira-health-inc-lhdx-q1-2022-earnings-call-trans/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article)

Also, Lucira does a significant amount of business, with 34 million in total revenue in the last quarter. Regardless of their negative EBITDA, that does suggest a fairly significant adoption of their product.

They are also working on other products, like Chlamydia and Gonorrhea testing.

If the eroding of our film industry test kit sales is inevitable, it could be nice to be in bed with a company like this.

Just my opinion.

JAGS




 

<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse